Adamis Pharmaceuticals Seeks Strategic Options, Including Sale
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) has initiated a process to explore a range of strategic and financing alternatives. The move follows the recently…
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Gainers
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
Adamis Announces Review Of Strategic Alternatives; May Include Partnership Or Sale Of One Or Both Of The Company’s Commercial Products Symjepi® And Zimhi®, A Merger, Sale, Or Reverse Merger Of The Company, And/or Seeking Additional Financing
SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million.
US Stocks Edge Higher As Fed Raises Interest Rates By 75 Basis Points
U.S. stocks traded slightly higher toward the end of trading session on Wednesday following the announcement of interest rate decision by the Fed.